Cite
HARVARD Citation
Xu, R. et al. (2017). Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study. Journal of hematology & oncology. 10 (1), pp. 1-8. [Online].